Thanks to the commitment of MAP researchers around the world and the generosity of the Human Para community to sponsor MAP research, there are three recent publications of interest.
March 4, 2024 In News By Moderator
Thanks to the commitment of MAP researchers around the world and the generosity of the Human Para community to sponsor MAP research, there are three recent publications of interest.
January 26, 2024 In News By Moderator
Dr. Click passed away on December 7, 2023. While we mourn his loss, we also celebrate the monumental contribution he made to advancing MAP science and hope that his tireless work with Dietzia may soon be celebrated by those afflicted by MAP-associated human disease.
November 3, 2023 In News By Moderator
HPF is proud to share the latest MAP research showcased by Dr. William Chamberlin at the 2023 UEG conference.
October 25, 2021 In News By Moderator
Human Paratuberculosis Foundation is dedicated to providing the latest research and information about the role of Mycobacterium avium subsp. paratuberculosis (MAP) in chronic immune conditions such as Crohn’s disease, multiple sclerosis, Type 1 diabetes, ulcerative colitis, sarcoidosis, Parkinson’s disease, rheumatoid arthritis, lupus and more. Our goal is to assist researchers, health care professionals and patients around the world. We are grateful for the support of our community and look forward to taking this journey together. Enjoy the latest edition of our quarterly newsletter!
October 21, 2021 In News By Moderator
In Maori the saying ‘Kua hinga te tōtara o Te Waonui a Tāne” roughly translates to “In the forest of Tāne a great Totara has fallen.” A Totara is a tree which was of great value. The proverb is used when a person of influence and mana passes on. It most certainly applies to Prof. John Hermon-Taylor.
June 22, 2021 In News By Moderator
April 18, 2021 In News By Moderator
Human Paratuberculosis Foundation is dedicated to providing the latest research and information about the role of Mycobacterium avium subsp. paratuberculosis (MAP) in chronic immune conditions such as Crohn’s disease, multiple sclerosis, Type 1 diabetes, ulcerative colitis, sarcoidosis, Parkinson’s disease, rheumatoid arthritis, lupus and more. Our goal is to assist researchers, health care professionals and patients around the world. We are grateful for the support of our community and look forward to taking this journey together. Enjoy the latest edition of our quarterly newsletter!
February 13, 2021 In News By Moderator
This week the world lost a friend, colleague and advocate for IBD patients. For decades, Patrick McLean dedicated his talents to advancing research into anti-mycobacterial treatment solutions for chronic immune diseases such as Crohn’s and multiple sclerosis. He had great compassion for patients, and exemplified the best of humanity. Our community was blessed to have known him, and he leaves a legacy that will ripple throughout time.
January 17, 2021 In News By Moderator
January 3, 2021 In News By Moderator
Human Paratuberculosis Foundation is dedicated to providing the latest research and information about the role of Mycobacterium avium subsp. paratuberculosis (MAP) in chronic immune conditions such as Crohn’s disease, multiple sclerosis, Type 1 diabetes, ulcerative colitis, sarcoidosis, Parkinson’s disease, rheumatoid arthritis, lupus and more. Our goal is to assist researchers, health care professionals and patients around the world. We are grateful for the support of our community and look forward to taking this journey together. Enjoy the latest edition of our quarterly newsletter!